27 Apr Co-Irbewin 300/12.5 mg, Tablets (Irbersatan &hydrochlorothiazide) and Irbewin 150 mg Tablets (irbersatan)
Company name & Address: registration number Batch number Expiry date Pack size First distributed Re-call Classification Re-call Date Sanofi-Aventis South Africa, 2 Bond Street Grand Central Ext. 01 Midrand 1685. 40/7.1.3/0287 AA550, AA507 August 2023 30 28 May 2020 Class II Type B 27 October 2021 40/7.1.3/0288 AA406 September 2023 30 12 February 2021 Class II Type B 27 October 2021 Reason for recall These products are being recalled due to...